keyword
https://read.qxmd.com/read/38595892/successful-treatment-of-mucus-plug-due-to-allergic-bronchopulmonary-aspergillosis-using-dupilumab
#1
Toshiyuki Sumi, Keito Suzuki, Yuta Koshino, Takumi Ikeda, Yuichi Yamada, Hirofumi Chiba
Allergic bronchopulmonary aspergillosis (ABPA) often necessitates treatment with systemic steroids and antifungals, which are associated with relapses and side effects. We report an 82-year-old woman with eosinophilic asthma, experiencing sputum production and dyspnea, who was diagnosed with ABPA based on her chest CT, pulmonary function tests, and elevated blood eosinophils and immunoglobulin E. Due to the presence of osteoporosis and diabetes, standard steroid therapy was considered a high risk. Instead, we administered dupilumab, an interleukin 4 receptor alpha (IL4-Rα) antibody targeting Th2 cytokine signaling...
March 2024: Curēus
https://read.qxmd.com/read/38474304/the-incredible-adventure-of-omalizumab
#2
REVIEW
Christian Domingo, Daniel R Monserrate, Ana Sogo, Rosa M Mirapeix
The basis of our current understanding of allergies begins with the discovery of IgE in the mid-1960s. The whole theory of the physiology and pathophysiology of allergic diseases, including rhinitis and asthma, dates from that period. Among the key regions of IgE identified were the FAB (fragment antigen binding) portion that has the ability to capture allergens, and the Cε3 domain, through which IgE binds to its membrane receptor. It was then postulated that blocking IgE at the level of the Cε3 domain would prevent it from binding to its receptor and thus set in motion the allergic cascade...
March 6, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38360857/bob1-maintains-t-follicular-helper-cells-for-long-term-humoral-immunity
#3
JOURNAL ARTICLE
Masahiro Yanagi, Ippei Ikegami, Ryuta Kamekura, Tatsuya Sato, Taiki Sato, Shiori Kamiya, Kosuke Murayama, Sumito Jitsukawa, Fumie Ito, Akira Yorozu, Miho Kihara, Takaya Abe, Hiromi Takaki, Koji Kawata, Katsunori Shigehara, Satsuki Miyajima, Hirotaka Nishikiori, Akinori Sato, Noritsugu Tohse, Ken-Ichi Takano, Hirofumi Chiba, Shingo Ichimiya
Humoral immunity is vital for host protection, yet aberrant antibody responses can trigger harmful inflammation and immune-related disorders. T follicular helper (Tfh) cells, central to humoral immunity, have garnered significant attention for unraveling immune mechanisms. This study shows the role of B-cell Oct-binding protein 1 (Bob1), a transcriptional coactivator, in Tfh cell regulation. Our investigation, utilizing conditional Bob1-deficient mice, suggests that Bob1 plays a critical role in modulating inducible T-cell costimulator expression and cellular respiration in Tfh cells...
February 15, 2024: Communications Biology
https://read.qxmd.com/read/38309959/-standard-technical-specifications-for-methacholine-chloride-methacholine-bronchial-challenge-test-2023
#4
JOURNAL ARTICLE
(no author information available yet)
The methacholine challenge test (MCT) is a standard evaluation method of assessing airway hyperresponsiveness (AHR) and its severity, and has significant clinical value in the diagnosis and treatment of bronchial asthma. A consensus working group consisting of experts from the Pulmonary Function and Clinical Respiratory Physiology Committee of the Chinese Association of Chest Physicians, the Task Force for Pulmonary Function of the Chinese Thoracic Society, and the Pulmonary Function Group of Respiratory Branch of the Chinese Geriatric Society jointly developed this consensus...
February 12, 2024: Chinese Journal of Tuberculosis and Respiratory Diseases
https://read.qxmd.com/read/38223972/-tezepelumab-tezspire%C3%A2-new-biological-treatment-of-severe-asthma
#5
JOURNAL ARTICLE
Florence Schleich, Mare Sabbe, Catherine Moermans, Renaud Louis
Here we present pharmacological and clinical properties of a new biological targeting TSLP (Thymic Stromal LymphoPoietin). Tezspire® is the name of this targeted treatment which contains 210 mg tezepelumab administered subcutaneously once a month. As compared to placebo, tezepelumab reduced exacerbations whatever the baseline blood eosinophil counts, exhaled nitric oxide (FeNO) level and atopic status. The response was higher in patients exhibiting the highest levels of blood eosinophils and FeNO. Tezepelumab also improved pre- bronchodilatation forced expiratory volume in one second, symptomatic control of asthma and quality of life...
January 2024: Revue Médicale de Liège
https://read.qxmd.com/read/38116349/an-unusual-case-of-eosinophilic-chronic-rhinosinusitis-with-concurrent-eosinophilic-otitis-media-limited-responsiveness-to-multiple-antibody-therapies-and-subsequent-cochlear-implantation
#6
Kosuke Urabe, Yumi Ohta, Soichiro Fujii, Takeshi Tsuda, Hidenori Inohara
Eosinophilic chronic rhinosinusitis (ECRS) and eosinophilic otitis media (EOM) are debilitating inflammatory conditions that affect the paranasal sinuses and middle ear, respectively, and are characterized by eosinophilic infiltration. This study describes a rare and intricate case of a 65-year-old male patient concurrently afflicted with ECRS, EOM, and bronchial asthma. Despite the systematic administration of corticosteroids and various antibody drugs, the patient's condition remained unimproved, necessitating a cochlear implant for EOM, which is seldom an aggressive intervention...
November 2023: Curēus
https://read.qxmd.com/read/37995367/-tezepelumab-a-new-option-for-the-treatment-of-severe-asthma
#7
REVIEW
Valente Armando Maldonado-Ríos, Juan Camilo Ardila-Herrera, Luz María Galicia-Sánchez, Carlos Andrés Celis-Preciado
In Latin America, asthma is a public health problem with a significant impact on both patients and health systems. The greater understanding of the pathophysiology and the recognition of the central role that inflammation has in the severity of asthma has favored the development of monoclonal antibodies that have IL-5, IL-4, IL-13 and IgE as therapeutic targets. Although these therapeutic alternatives promote better control of the disease, not all patients respond favorably to these treatments. Therefore, it is of particular interest to explore monoclonal antibodies such as Tezepelumab, directed against thymic stromal lymphopoietin (TSLP), an alarmin (epithelial cytokine) that participates in the initiation and perpetuation of inflammation in Asthma...
November 6, 2023: Revista Médica del Instituto Mexicano del Seguro Social
https://read.qxmd.com/read/37987248/elevated-ige-levels-an-allergy-or-an-underlying-inborn-error-of-immunity-in-children-with-recurrent-infections
#8
JOURNAL ARTICLE
Polina Kostova, Vera Papochieva, Dimitrinka Miteva, Bilyana Georgieva, Sirma Mileva, Martin Shahid, Tsvetelin Lukanov, Guergana Petrova
Elevated immunoglobulin E (IgE) is a hallmark of allergic diseases. However, high IgE levels also occur in a number of other infectious and noninfectious diseases. In most cases, elevated IgE levels indicate allergy, eczema, or chronic skin infection. Very high IgE levels are not uncommon in patients with active eczema but more often indicate monogenic atopic disorder or inborn errors of immunity with an atopic phenotype. We conducted a retrospective study of 385 children with suspected immune deficiency referred to the clinic over a 9-year period...
November 3, 2023: Antibodies
https://read.qxmd.com/read/37933943/-perfilamiento-del-paciente-con-asma-grave-eosinof%C3%A3-lica-para-el-tratamiento-biol%C3%A3-gico-con-mepolizumab-y-su-efectividad-en-el-control-de-la-enfermedad
#9
JOURNAL ARTICLE
Zayra Ortiz-Monteón, Ruiz Peñaloza-Martha
BACKGROUND: Management of severe eosinophilic asthma includes typing to identify allergic, eosinophilic and non-HT2 phenotypes. Elevated eosinophil levels are associated with higher IL-5 levels. Eosinophils during their migration to target tissues secrete proteins that damage the activated bronchial epithelium and correlate with asthma severity. Mepolizumab, a humanized monoclonal antibody that binds and neutralizes IL-5. OBJECTIVES: To describe experience with the use of biological anti interleukin 5 Mepolizumab...
September 2023: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/37839999/clinical-characteristics-in-japanese-patients-with-chronic-rhinosinusitis-who-underwent-endoscopic-sinus-surgery
#10
JOURNAL ARTICLE
Natsuki Inoue, Tomomitsu Hirota, Akihiro Hatano, Mika Nakano, Daiki Nakashima, Tsuguhisa Nakayama, Mayumi Tamari, Mamoru Yoshikawa
OBJECTIVE: There is heterogeneity in the pathophysiology of chronic rhinosinusitis (CRS). Obtaining a detailed understanding of patient profiles in specific regions can provide valuable information not only for clinical practice but also future research plans. The aim of this study was to investigate the characteristics of patients who underwent endoscopic sinus surgery (ESS) for CRS. METHODS: This retrospective, single-center study examined the features of 453 patients with CRS who underwent ESS in the Tokyo area of Japan...
October 13, 2023: Auris, Nasus, Larynx
https://read.qxmd.com/read/37799220/clinical-microbiological-serological-and-radiological-profile-of-patients-with-mild-moderate-and-severe-allergic-bronchopulmonary-aspergillosis-abpa
#11
JOURNAL ARTICLE
Amardeep Singh, Umma Sadia Tomo, Manoj Kumar Dodiya, Pankaj K Singh, Abdul Manan, Inimerla Bhavya, Varsha S Kumar, Irfan A Mir
Objective Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction to Aspergillus antigen mostly Aspergillus fumigatus that occurs almost exclusively in patients with asthma and cystic fibrosis. ABPA is an underdiagnosed and undertreated disease because of its presentation with various grades of severity in asthma patients. Data available regarding the clinical, serological, and radiological profile of ABPA patients is limited due to lack of consensus on diagnostic criteria and treatment guidelines...
September 2023: Curēus
https://read.qxmd.com/read/37763288/eosinophil-cationic-protein-variation-in-patients-with-asthma-and-crswnp-treated-with-dupilumab
#12
JOURNAL ARTICLE
Andrea Giovanni Ledda, Giulia Costanzo, Giada Sambugaro, Cristiano Caruso, Martina Bullita, Maria Luisa Di Martino, Paolo Serra, Davide Firinu, Stefano Del Giacco
BACKGROUND: Asthma is a clinical syndrome characterized by recurrent episodes of airway obstruction, bronchial hyperresponsiveness and airway inflammation. Most patients with asthma present a "type 2" (TH2) inflammation. ILC2 and TH2 cells release cytokines IL4, IL-13 and IL-5. CRSwNP is a condition characterized by hyposmia or anosmia, nasal congestion, nasal discharge, and face pain or pressure that last for at least 12 weeks in a row without relief. Both asthma and CRSwNP are often characterized by a type 2 inflammation endotype and are often present in the same patient...
September 8, 2023: Life
https://read.qxmd.com/read/37654153/-omalizumab-treats-aspirin-induced-asthma-complicated-with-nasosinusitis-and-otitis-media-report-of-one-case
#13
JOURNAL ARTICLE
Rui Tang, Shu-Bin Lei, Yi Wang
Omalizumab,as a biological agent targeting IgE,is a recombinant humanized monoclonal antibody and the first targeted drug approved for treating moderate-to-severe bronchial asthma.By reviewing one case of aspirin-induced asthma complicated with nasosinusitis and otitis media,we discussed the value of omalizumab in the treatment of asthma and its complications,aiming to provide a reference for clinical practice.
August 2023: Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
https://read.qxmd.com/read/37122191/a-case-of-bullous-pemphigoid-developing-under-treatment-with-benralizumab-for-bronchial-asthma
#14
JOURNAL ARTICLE
Arisa Tanaka, Yu Fujimura, Satoshi Fuke, Kentaro Izumi, Hideyuki Ujiie
Bullous pemphigoid (BP) is an autoimmune disease characterized by itchy erythema and tense blisters on the whole body. Recent reports have unveiled the pathogenic roles of eosinophils in BP (e.g., dermal-epidermal separation, generation of pruritus). Thus, eosinophils are considered a therapeutic target. Benralizumab is an anti-IL-5 receptor alpha (IL-5Rα) monoclonal antibody (mAb) that is widely used to treat severe eosinophilic asthma. By affecting IL-5Rα, benralizumab depletes eosinophils and basophils due to apoptosis through antibody-dependent cell-mediated cytotoxicity...
September 2023: Journal of Dermatology
https://read.qxmd.com/read/36959028/executive-summary-japanese-guidelines-for-adult-asthma-jgl-2021
#15
REVIEW
Akio Niimi, Koichi Fukunaga, Masami Taniguchi, Yoichi Nakamura, Etsuko Tagaya, Takahiko Horiguchi, Akihito Yokoyama, Masao Yamaguchi, Makoto Nagata
Asthma is characterized by chronic airway inflammation, variable airway narrowing, and sensory nerve irritation, which manifest as wheezing, dyspnea, chest tightness, and cough. Longstanding asthma may result in airway remodeling and become intractable. Despite the increased prevalence of asthma in adults, asthma-associated deaths have decreased in Japan (0.94 per 100,000 people in 2020). The goals of asthma treatment include the control of symptoms and reduction of future risks. A functional partnership between physicians and patients is indispensable for achieving these goals...
March 21, 2023: Allergology International: Official Journal of the Japanese Society of Allergology
https://read.qxmd.com/read/36910311/toxocariasis-potential-association-with-bronchial-asthma-and-pneumonia-among-pediatric-children
#16
JOURNAL ARTICLE
Wegdan M Abd El Wahab, Mona I Ali, Shimaa S Ibrahim, Yasmen A Mohamed, Doaa A Hamdy
Toxocariasis is an underestimated geohelminthic infection which shows respiratory changes concurrent with larval migration. The purpose of the present study was to detect Toxocara seropositivity in asthmatic and pneumonic children, and in turn to evaluate its association with the children clinical manifestations, laboratory test results, and sociodemographic risk factors. A total of 50 asthmatic, 50 pneumonic children and 50 healthy controls were subjected to stool analysis by direct wet mount and concentration techniques to exclude possible cross reactivity...
March 2023: Journal of Parasitic Diseases: Official Organ of the Indian Society for Parasitology
https://read.qxmd.com/read/36843075/continuous-ingestion-of-sodium-chloride-solution-promotes-allergen-absorption-and-may-exacerbate-allergy-symptoms-on-ovalbumin-induced-food-allergy-in-mice
#17
JOURNAL ARTICLE
Mamoru Tanaka, Rui Lu, Hana Kozai
Various studies have reported relationships between salt intake and diseases, such as hypertension, cardiovascular disease, stroke, gastric cancer, and bronchial asthma. However, no reports exist on the relationship between salt intake and food allergies. In this study, we investigated the effect of continuous ingestion of sodium chloride (NaCl) on allergy symptoms using a mouse model of food allergy. BALB/c mice were divided into four groups of 6-8 animals each. The control-water group (CW) and sensitization-water group (SW) groups were provided free access to water, and the control-1% NaCl group (CS) and sensitization-1% NaCl group (SS) groups were provided a 1% NaCl solution...
February 25, 2023: Drug Discoveries & Therapeutics
https://read.qxmd.com/read/36756389/treatment-of-severe-cow-s-milk-allergy-with-omalizumab-in-an-adult
#18
Benjamin Klein, Jan Christoph Simon, Regina Treudler
BACKGROUND: The therapy of severe food allergy so far consists mainly of allergen abstinence and emergency treatment. The use of anti-IgE antibodies represents a promising therapy. CASE REPORT: We report on a 22-year-old male with severe cow's milk allergy with multiple anaphylactic reactions, known since infancy and persisting into adulthood with sometimes severe immediate-type reactions on accidental ingestion. The prick test for native whole milk was positive, the CAP-FEIA was also positive for milk protein, mare's milk, whey, sheep's milk whey as well as Bos d4, Bos d5, and Bos d8 and blue cheese; total IgE was 1,265 kU/L...
2023: Allergologie Select
https://read.qxmd.com/read/36719697/eosinophilic-granulomatosis-with-polyangiitis-in-allergic-asthma-efforts-to-make-early-diagnosis-possible
#19
REVIEW
Bo Zhao, Haiming Zheng, Tengfei Yang, Rui Zheng
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare autoimmune disease that can affect multiple organ systems in the body. A majority of patients with EGPA present with asthma-like symptoms and may be misdiagnosed with refractory asthma. It is necessary to distinguish EGPA from asthma and provide a theoretical basis for effective future prevention and treatment. Objective: This study aimed to compare the clinical features of EGPA and the clinical features of allergic asthma in an effort to make an early diagnosis possible...
January 1, 2023: Allergy and Asthma Proceedings:
https://read.qxmd.com/read/36430941/human-lung-mast-cells-therapeutic-implications-in-asthma
#20
REVIEW
Remo Poto, Gjada Criscuolo, Gianni Marone, Chris E Brightling, Gilda Varricchi
Mast cells are strategically located in different compartments of the lung in asthmatic patients. These cells are widely recognized as central effectors and immunomodulators in different asthma phenotypes. Mast cell mediators activate a wide spectrum of cells of the innate and adaptive immune system during airway inflammation. Moreover, these cells modulate the activities of several structural cells (i.e., fibroblasts, airway smooth muscle cells, bronchial epithelial and goblet cells, and endothelial cells) in the human lung...
November 21, 2022: International Journal of Molecular Sciences
keyword
keyword
98371
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.